Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study

Lupus

Volumn 19, Issue 8, 2010, Pages 918-926

  Mathieu, A ^a   Vacca, A ^a   Serra, A ^a   Cauli, A ^a   Piga, M ^a   Porru, G ^a   Marrosu, F ^a   Sanna, G ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

123I Iomazenil brain SPECT; 99mTc ECD brain SPECT; central nervous system; cognitive defects; GABA A receptor; systemic lupus erythematosus

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CYSTEINE ETHYL ESTER TC 99M; IODINE 123; IOMAZENIL; IOMAZENIL I 123; UNCLASSIFIED DRUG; FLUMAZENIL; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AMNESIA; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; FEMALE; GENE EXPRESSION; HUMAN; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; ANALOGS AND DERIVATIVES; BRAIN CIRCULATION; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CHEMISTRY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PROCEDURES; SCINTISCANNING; ULTRASTRUCTURE;

ADULT; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; FEMALE; FLUMAZENIL; HUMANS; IODINE RADIOISOTOPES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PREGNANCY; RADIOPHARMACEUTICALS; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77954058686     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310364398     Document Type: Article

References (35)

1. Hanly JG, Fisk JD, Sherwood G., Jones E., Jones JV, Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992 ; 19: 562-567.
2. Hay EM, Black D., Huddy A., et al. Psychiatric disorders and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992 ; 35: 411-416.
3. Newman SP Cognitive changes in systemic lupus erythematosus. Baillieres Clin Rheum 1993 ; 7: 357-376.
4. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999 ; 42: 599-608.
5. Abi-Dargham A., Gandellman M., Zoghbi SS Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with Iodine-123- Iomazenil. J Nucl Med 1995 ; 36: 167-175.
6. Onishi Y., Yonekura Y., Nishizawa S., Tanaka F. Noninvasive qualification of Iodine-123-Iomazenil SPECT. J Nucl Med 1996 ; 37: 374-378.
7. Abi-Dargham A., Laruelle M., Seibyl J., Rattner Z., Baldwin RM, Zoghbi SS SPECT measurement of benzodiazepine receptors in human brain Iodine-123-Iomazenil: kinetic and equilibrium paradigms. J Nucl Med 1994 ; 35: 228-238.
8. Borbely K. Functional imaging (PET and SPECT) in epilepsy. Orv Hethyl 2001 ; 142: 2405-2414.
9. Marrosu F., Serra A., Maleci A., Puligheddu M., Biggio G., Piga M. Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res 2003 ; 55: 59-70. (Pubitemid 37011373)
10. Morimoto K., Watanabe T., Ninomiya T., et al. Quantitative evaluation of central-type benzodiazepine receptors with [(125)I] Iomazenil in experimental epileptogenesis: II. The rat cortical dysplasia model. Epilepsy Res 2004 ; 61: 113-118. (Pubitemid 39296703)
11. Abi-Dargham A., Krystal JH, Anjilvel S., et al. Alterations of benzodiazepine receptors in type II alchoolic sibjects measured with SPECT and [123I] iomazenil. Am J Psychiatry 1998 ; 155: 1550-1555.
12. Lingford-Hughes AR, Acton PD, Gacinovic S., et al. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. Br J Psychiatry 1998 ; 173: 116-122.
13. Bremner JD, Inis RB, White T., et al. SPECT [I-123] iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 2000 ; 15: 96-106.
14. Schroder J., Bubeck B., Demish S., Sauer H. Benzodiazepine receptor distribution and diazepam binding in schizophrenia: an exploratory syudy. Psychiatry Res 1997 ; 68: 125-131.
15. Ohyama M., Senda M., Ishiwata K., et al. Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF. Ann Nucl Med 1999 ; 13: 309-315.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 ; 25: 1271-1277.
17. Mathieu A., Sanna G., Mameli A., et al. Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus. Lupus 2002 ; 11: 52-56.
18. DeLorey TM, Lin RC, McBrady B., et al. Influence of benzodiazepine binding site ligands on fear-conditioned contextual memory. Eur J Pharmacol 2001 ; 426: 45-54.
19. Diez-Ariza M., Redondo C., Garcia-Alloza M., Lasheras B., Del Rio J., Ramirez MJ Flumazenil and taurine increase the effectiveness of ondastreon on scopolamine-induced impairment of spatial learning in rats. Psychopharmacology 2003 ; 169: 35-41.
20. Maubach K. GABA(A) receptor subtype selective cognition enhancers. Curr Drug Targets CNS Neurol Disord 2003 ; 2: 233-239.
21. Johnston GA, Chebib M., Hanrahan JR, Mewett KN GABA(C) receptors as drug targets. Curr Drug Targets CNS Neurol Disord 2003 ; 2: 260-269.
22. Rissman RA, Bennett DA, Armstrong DM Subregional analysis of GABA(A) receptor subunit mRNAs in the hippocampus of older persons with and without cognitive impairment. J Chem Neuroanat 2004 ; 28: 17-25.
23. Goodwin GM Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J Psychopharmacol 1997 ; 11: 115-122.
24. Kugaya A., Sanacora G., Verhoeff NP, et al. Cerebral benzodiazepine receptors in depressed patients measured with [123I] iomazenil SPECT. Biol Psychiatry 2003 ; 15: 792-799.
25. Muller V., Saur D., Klutmann S., Weiller C., Rother J., Clausen M. Experience with 123I-iomazenil SPECT in acute cerebral infarction. Nucl Med Commun 2002 ; 23: 1191-1196.
26. Hatazawa J., Shimosegawa E. Imaging neurochemistry of cerebrovascular disease with PET and SPECT. Q J Nucl Med 1998 ; 42: 193-198.
27. Nakagawara J., Sperling B., Lassen NA Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke 1997 ; 28: 124-132.
28. Shuke N., Hashizume K., Kiruyama K., et al. Correct localization of epilectogenic focus with I-123 iomazenil cerebral benzodiazepine receptor imaging: a case report of temporal lobe epilepsy with discordant ictal cerebral blood flow SPECT. Ann Nucl Med 2004 ; 18: 541-545.
29. Rasmussen LS, Sperling B., Abildstrom HH, Moller JT Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors. Ann Thorac Surg 2002 ; 74: 1576-1580.
30. Sanna G., Piga M., Terryberry JW, et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000 ; 9: 573-583.
31. Liou HH, Wang CR, Chou HC, et al. Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons. Life Sci 1994 ; 54: 1119-1125.
32. De Souza EB, Goeders NE, Kuhar MJ Benzodiazepine receptors in rat brain are altered by adrenalectomy. Brain Res 1986 ; 381: 176-181.
33. Ariyoshi M., Akasu T. Glucocorticoids modulate the sensitivity of GABA A receptor on primary afferent neurons of bullfrogs. Brain Res 1986 ; 367: 332-336.
34. Liu L., Katz Y., Weizman R., Rosenberg B., Pasternak GW, Gavish M. Interactions of chloroquine with benzodiazepine, gamma-aminobutyric acid and opiate receptors. Biochem Pharmacol 1991 ; 41: 1534-1536.
35. Amabeoku GJ, Chikuni O. Effects of some GABAergic agents on quinine-induced seizures in mice. Experientia 1992 ; 48: 659-662.